Inhibitors of type II 17beta-hydroxysteroid dehydrogenase (Q31875242)

4 July 2017

title

Inhibitors of type II 17beta-hydroxysteroid dehydrogenase (English)

1 reference

4 July 2017

1 reference

Poirier D

1

1 reference

4 July 2017

Bydal P

2

1 reference

4 July 2017

Tremblay MR

3

1 reference

4 July 2017

Sam KM

4

1 reference

4 July 2017

Luu-The V

5

1 reference

4 July 2017

publication date

1 January 2001

1 reference

Molecular and Cellular Endocrinology

4 July 2017

published in

1 reference

4 July 2017

volume

171

1 reference

4 July 2017

issue

1-2

1 reference

4 July 2017

page(s)

119-128

1 reference

Molecular genetics of androgenic 17 beta-hydroxysteroid dehydrogenases

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Crystal structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase complexed with 17 beta-estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Kinetic analysis of enzymic activities: prediction of multiple forms of 17 beta-hydroxysteroid dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Gestational development of human placental 17 beta-hydroxysteroid oxidoreductase types 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Inhibition of 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) activities of human placenta by steroids and non-steroidal hormone agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

17 beta-hydroxysteroid and 20 alpha-hydroxysteroid dehydrogenase activities of human placental microsomes: kinetic evidence for two enzymes differing in substrate specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

A comparison of 17 beta-hydroxysteroid oxidoreductase type 1 and type 2 activity of cytosol and microsomes from human term placenta, ovarian stroma and granulosa-luteal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Intracellular regulation of 17 beta-hydroxysteroid dehydrogenase type 2 catalytic activity in A431 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Novel steroidal pure antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Characterization of 17 beta-hydroxysteroid dehydrogenase activity and mRNA abundance in human meningioma tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

17 beta-Hydroxysteroid dehydrogenase activity correlates with the type-2 17 beta-hydroxysteroid dehydrogenase mRNA abundance in human meningioma tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Danazol—a Synthetic Steroid Derivative with Interesting Physiologic Properties

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Mapping of the HSD17B2 gene encoding type II 17 beta-hydroxysteroid dehydrogenase close to D16S422 on chromosome 16q24.1-q24.2

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Characterization of 17beta-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Structure of human estrogenic 17β-hydroxysteroid dehydrogenase at 2.20 å resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Synthesis and biological activity of new halo-steroidal antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

3D-structure of human estrogenic 17beta-HSD1: binding with various steroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Characteristics of human types 1, 2 and 3 17 beta-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Distribution of 17 beta-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Unusual charge stabilization of NADP+ in 17beta-hydroxysteroid dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Human 17 beta-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Inhibition of microsomal 17 beta-hydroxysteroid oxidoreduction activities in rat liver by all-trans-, 9-cis- and 13-cis-retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Mechanism Based Inhibition of Hydroxysteroid Dehydrogenases

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

A 6beta-(thiaheptanamide) derivative of estradiol as inhibitor of 17beta-hydroxysteroid dehydrogenase type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Characterization of molecular and catalytic properties of intact and truncated human 17beta-hydroxysteroid dehydrogenase type 2 enzymes: intracellular localization of the wild-type enzyme in the endoplasmic reticulum.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

The interconversion of estrone and estradiol by human tissue slices

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Steroidal spiro-gamma-lactones that inhibit 17 beta-hydroxysteroid dehydrogenase activity in human placental microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

N-Butyl-N-methyl-11-(3'-hydroxy-21', 17'-carbolactone-19'-nor-17'alpha-pregna-1',3', 5'(10')-trien-7'alpha-yl)-undecanamide: an inhibitor of type 2 17beta-hydroxysteroid dehydrogenase that does not have oestrogenic or androgenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Structure of the ternary complex of human 17beta-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Androsterone 3beta-substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Overview of a rational approach to design type I 17beta-hydroxysteroid dehydrogenase inhibitors without estrogenic activity: chemical synthesis and biological evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Spironolactone-related inhibitors of type II 17beta-hydroxysteroid dehydrogenase: chemical synthesis, receptor binding affinities, and proliferative/antiproliferative activities

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

Steroidal pure antioestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900427-5

7 January 2021

10.1016/S0303-7207(00)00427-5

Identifiers

DOI

1 reference

4 July 2017

1 reference